Immuneering (IMRX) Other Accumulated Expenses (2022 - 2026)

Immuneering's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $44191.0 for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 21.83% year-over-year to $44191.0 in Q1 2026; TTM through Mar 2026 was $44191.0, a 21.83% decrease from a year earlier, with the FY2025 full-year figure at $291513.0, up 24.76% from the prior year.
• Other Accumulated Expenses eased to $44191.0 in Q1 2026 per IMRX's latest filing, from $291513.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $291513.0 in Q4 2025 and bottomed at $19796.0 in Q4 2022.
• The 5-year median for Other Accumulated Expenses is $56531.0 (2025), against an average of $96526.3.
• Biggest YoY gain for Other Accumulated Expenses was 1212.23% in 2023; the steepest drop was 44.23% in 2023.
• Year by year, Other Accumulated Expenses stood at $19796.0 in 2022, then soared by 1212.23% to $259770.0 in 2023, then decreased by 10.05% to $233665.0 in 2024, then climbed by 24.76% to $291513.0 in 2025, then slumped by 84.84% to $44191.0 in 2026.
• Per Business Quant, the three latest IMRX Other Accumulated Expenses figures stand at $44191.0 (Q1 2026), $291513.0 (Q4 2025), and $80089.0 (Q3 2025).